Applied Spectral Imaging Inc.

What Applied Spectral Imaging Inc. does

Applied Spectral Imaging Inc. (legal entity: Applied Spectral Imaging Ltd.) is a privately held medical imaging technology company headquartered in Carlsbad, California, with approximately three decades of operating history (founded circa 1993-1995). The company develops computer-aided solutions for digital cytogenetics and pathology, organized around two integrated platform families: a Cytogenetics Platform (HiBand for AI-powered karyotyping, HiFISH for digital fluorescence in situ hybridization scanning and analysis, and CytoPower for workflow management) and a Pathology Platform (HiPath Pro for scanner-agnostic H&E and IHC analysis with AI-powered biomarker quantification for PD-L1, HER2, and Ki-67, plus PathFusion for combined brightfield and fluorescent imaging). The technology stack combines proprietary spectral imaging with computer vision and deep learning applied to high-resolution medical images (metaphase chromosome spreads, FISH specimens, and stained tissue slides), and is built to be scanner-agnostic so it can interoperate with existing laboratory equipment.

The company's customer base consists primarily of clinical and research cytogenetic laboratories and pathology laboratories, including tier-one academic medical centers such as Cleveland Clinic, Montefiore, and Duke University Health System, alongside international institutions such as Lancet Laboratories (South Africa), Soroka Medical Center (Israel), and Mendel Laboratories (Mexico). Revenue is generated through a combination of software licenses and subscriptions for the analysis platforms, alongside one-time consumable sales of probe kits and reagents (HiSKY Probe Kit, Whole Chromosome Paints, and the Zytomics ISH probe line). Pricing is quote-based and not publicly disclosed. Distribution is primarily carried out through a global network of distribution partners covering over 80 countries, with direct sales retained for North America; website-based ordering supports direct probe and reagent purchases. Marketing is delivered through content (blog, webinars, peer-reviewed clinical publications), industry conferences (ESHG, ECP, Cancer Genomics Consortium), and an active social presence on LinkedIn, X (Twitter), and YouTube.

Operationally, the company has no disclosed institutional or venture investor backing and operates as a founder-led private entity. There are no disclosed M&A transactions, leadership changes, or funding rounds in the source material, and ownership and investor structure constitute an identified data gap. The company maintains an actively updated website and ongoing participation in international scientific conferences, signaling continued operating activity.

Name

Applied Spectral Imaging Inc.

Legal name

Applied Spectral Imaging Ltd.

Website

https://spectral-imaging.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Short description

Applied Spectral Imaging (ASI) develops AI-powered computer-aided imaging software for clinical cytogenetics and pathology laboratories, including HiBand karyotyping, HiFISH, HiPath Pro, and PathFusion, distributed through a partner network in over 80 countries to hospital and reference laboratories.

Ownership category

akta.pro rank

Product category

Digital Pathology and Cytogenetics Software

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

akta.pro secondary industries

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Medical Imaging AI (HDAAAEAH)

Keywords

• Digital cytogenetics software
• AI karyotyping platforms
• FISH image analysis
• Digital pathology software
• Biomedical imaging diagnostics

Headquarters

HQ city

Carlsbad

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Software Licenses and Subscriptions: ASI sells software licenses for its digital cytogenetics and pathology platforms. The company offers computer-aided solutions for karyotyping, FISH analysis, and digital pathology imaging. Products include HiBand, HiFISH, HiPath Pro, and PathFusion systems.
2. Probe Kits and Consumables: Sale of HiSKY Probe Kit and Whole Chromosome Paints for FISH and cytogenetic applications. These are physical consumable products ordered through the website or distributors.
3. Zytomics ISH Probes: Distribution of ISH (In Situ Hybridization) probes through Zytomics brand, expanding the probe product portfolio for genetic diagnostics.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

Applied Spectral Imaging (ASI) develops and sells computer-aided software platforms that automate digital cytogenetics and pathology workflows for diagnostic laboratories. Its product portfolio includes AI-powered karyotyping (HiBand), digital FISH scanning and analysis (HiFISH), cytogenetics workflow (CytoPower), AI-driven H&E and IHC quantification (HiPath Pro), and an integrated brightfield/fluorescence diagnostic platform (PathFusion). The company also distributes probe kits and consumables (HiSKY Probe Kit, Whole Chromosome Paints, Zytomics ISH probes) used alongside its software for genetic and cancer diagnostics.

Product overview

Applied Spectral Imaging (ASI) offers a comprehensive suite of computer-aided solutions for digital cytogenetics and digital pathology. The product portfolio is organized into two integrated platform families: the Cytogenetics Platform (featuring HiBand for AI-powered karyotyping, HiFISH for digital FISH analysis, and CytoPower for workflow management) and the Pathology Platform (featuring HiPath Pro for H&E and IHC analysis and PathFusion for combined brightfield/fluorescent imaging). Both platforms are scanner-agnostic and designed to work with images from various acquisition systems. The company also offers reagent products including HiSKY Probe Kits, Whole Chromosome Paints, and Zytomics ISH probes. ASI's solutions cater to brightfield, fluorescence, and spectral imaging and analysis for diagnostic laboratories worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• HiBand: AI-powered karyotyping and chromosome analysis platform for cytogenetics.
• HiFISH
• CytoPower
• HiPath Pro
• PathFusion
• Zytomics

Products and services

• HiBand AI-powered digital cytogenetics platform for aided karyotyping that automates chromosome identification, classification, and karyogram generation, with clinical studies reporting 4x improvement in chromosome classification accuracy and 52% reduction in analysis time.
• HiFISH Digital fluorescence in situ hybridization (FISH) scanning and analysis platform that automates FISH image capture, storage, and analysis, with clinical studies showing 40% reduction in analysis time versus manual methods.
• CytoPower Cytogenetics platform combining digital karyotyping (HiBand) and FISH scanning and analysis (HiFISH) into a unified aided-karyotyping and FISH workflow for clinical cytogenetic laboratories.
• HiPath Pro Scanner-agnostic digital pathology platform for H&E and IHC tissue analysis with AI-powered quantification supporting PD-L1 scoring, HER2 assessment, and Ki-67 analysis.
• PathFusion Integrated digital pathology platform that combines brightfield (H&E/IHC) and fluorescent (FISH) imaging, enabling tissue matching with FISH specimens and comprehensive diagnostic reporting.
• Cytogenetics Platform Unified portfolio of digital cytogenetics software featuring aided karyotyping and FISH scanning and analysis for brightfield, fluorescence, and spectral imaging in clinical labs.
• Pathology Platform Scanner-agnostic digital pathology platform supporting H&E and IHC analysis with integrated FISH specimen data for comprehensive diagnostic workflows.
• HiSKY Probe Kit FISH probe kit ordered through the ASI website, enabling detection of specific genetic sequences used alongside HiBand and HiFISH for cytogenetic and spectral karyotyping applications.
• Whole Chromosome Paints Chromosome painting reagents for spectral karyotyping, used by cytogenetic labs to label and visualize individual chromosomes in research and diagnostic workflows.
• Zytomics ISH Probes ISH (in situ hybridization) probes including FISH and CISH probes offered by ASI under the Zytomics brand for precision genetic and cancer diagnostics.

Quantifiable outcome

• 4-fold improvement in chromosome classification accuracy
• +5 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• ZytomicscoreChannel Partner/ Reseller/ DistributorZytomics is a brand offering ISH (In Situ Hybridization) probes, now offered by ASI Inc. This partnership expands ASI's probe portfolio for customers requiring FISH and CISH probes for genetic diagnostics.
• Global Distribution Partners NetworkcoreChannel Partner/ Reseller/ DistributorStrong partnerships with prominent distributors across all continents enabling delivery of ASI's comprehensive portfolio of biomedical imaging solutions to research and clinical communities worldwide. Over 30 years of collaborative global reach.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Hamamatsu Photonics: Manufacturer of slide scanners (NanoZoomer) used widely in digital pathology. Competes indirectly with ASI where labs adopt Hamamatsu's full-stack scanning + analysis solution rather than ASI's scanner-agnostic overlay.
• Philips Digital Pathology: Philips IntelliSite Pathology Solution is an enterprise digital pathology platform combining scanners and image management. Competes in the same hospital pathology digitalization workflow as ASI's HiPath Pro.
• Leica Biosystems (Danaher): Major digital pathology and histology incumbent (Aperio, BOND, scanner portfolio) with broad life-science instrumentation reach. Overlaps with ASI in H&E/IHC digital pathology and FISH analysis but serves a much wider portfolio of customers and modalities.
• Roche Digital Pathology (Ventana): Roche's digital pathology business offers companion algorithms (e.g., uPath, PD-L1, HER2) bundled with scanning hardware. A scaled, vertically integrated incumbent competing for the same pathology AI workloads ASI targets.

Emerging players

• Indica Labs: Digital pathology AI platform (HALO) used for tissue image analysis in pharma and clinical research. Competes for AI pathology analysis workloads, especially in pharma/biopharma research contexts adjacent to ASI's pathology research offering.
• Visiopharm: AI-driven image analysis and digital pathology software provider for cancer diagnostics. Overlaps with ASI's HiPath Pro in IHC biomarker quantification (HER2, Ki-67, PD-L1) but does not address the cytogenetics/karyotyping workflows.
• OptraScan: Digital pathology scanner and AI workflow vendor targeting emerging markets and smaller labs. A scanner-agnostic philosophy and price-point competitor to ASI in regional/enterprise accounts.
• 3DHISTECH: Digital pathology company offering slide scanners (P1000, P250) and analysis software. Comparable focus on digital pathology workflows but with a narrower international footprint than ASI.

Direct peers

• MetaSystems: Direct competitor offering automated karyotyping and FISH scanning/analysis platforms (e.g., Metafer for metaphase finding, ISIS/iFISH for FISH analysis) to cytogenetics laboratories worldwide. Closely comparable product portfolio, customer base, and AI-driven analysis value proposition.
• BioView: Provider of automated FISH scanning and analysis systems for clinical and research cytogenetics labs. Comparable in targeting the same cytogenetics workflow (scanning + AI interpretation of FISH and chromosomes) and overlapping customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/asimaging
• YouTubeyoutube.com/@Spectral-imaging/playlists
• LinkedInlinkedin.com/company/applied-spectral-imaging
• Facebookfacebook.com/asimaging

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Applied Spectral Imaging Inc.